Skip to main content

Nurix Therapeutics, Inc.

NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001549595

In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q2 2022

Institutional positions in Nurix Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
106
−9 vs. Q1 2022
Shares held
45.0M
+4.65M (+11.5%) vs. Q1 2022
Total value
$568.4M
+$3.32M (+0.6%) vs. Q1 2022
New holders
13
46 more added
Sold out
22
30 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 106 institutions
Q1 2021: 101 institutionsQ2 2021: 104 institutionsQ3 2021: 113 institutionsQ4 2021: 125 institutionsQ1 2022: 117 institutionsQ2 2022: 106 institutionsQ3 2022: 118 institutionsQ4 2022: 119 institutionsQ1 2023: 124 institutionsQ2 2023: 126 institutionsQ3 2023: 129 institutionsQ4 2023: 131 institutionsQ1 2024: 139 institutionsQ2 2024: 174 institutionsQ3 2024: 172 institutionsQ4 2024: 175 institutionsQ1 2025: 170 institutionsQ2 2025: 164 institutionsQ3 2025: 173 institutionsQ4 2025: 182 institutionsQ1 2026: 196 institutionsQ2 2026: 211 institutions
Value heldQ2 2022: $568.4M
Q1 2021: $1.29BQ2 2021: $1.05BQ3 2021: $1.18BQ4 2021: $1.17BQ1 2022: $565.6MQ2 2022: $568.4MQ3 2022: $561.0MQ4 2022: $468.6MQ1 2023: $376.6MQ2 2023: $435.7MQ3 2023: $352.5MQ4 2023: $475.6MQ1 2024: $721.3MQ2 2024: $1.36BQ3 2024: $1.53BQ4 2024: $1.53BQ1 2025: $1.01BQ2 2025: $1.01BQ3 2025: $783.3MQ4 2025: $2.15BQ1 2026: $1.81BQ2 2026: $2.84B
Institutions holding NRIX and their total value by quarter
QuarterHoldersValue
Q2 2026211$2.84B
Q1 2026196$1.81B
Q4 2025182$2.15B
Q3 2025173$783.3M
Q2 2025164$1.01B
Q1 2025170$1.01B
Q4 2024175$1.53B
Q3 2024172$1.53B
Q2 2024174$1.36B
Q1 2024139$721.3M
Q4 2023131$475.6M
Q3 2023129$352.5M
Q2 2023126$435.7M
Q1 2023124$376.6M
Q4 2022119$468.6M
Q3 2022118$561.0M
Q2 2022106$568.4M
Q1 2022117$565.6M
Q4 2021125$1.17B
Q3 2021113$1.18B
Q2 2021104$1.05B
Q1 2021101$1.29B

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Nurix Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding NRIX in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Wasatch Advisors Inc2,263,063$28.7M0.18%+716,374+46.3%Added
Deep Track Capital, LP2,436,164$30.9M2.13%+2,436,164New
Redmile Group, LLC3,006,684$38.1M1.45%−12,100−0.4%Reduced
BlackRock Inc.3,355,347$42.5M0.00%+830,704+32.9%Added
Baker Bros. Advisors LP3,882,125$49.2M0.28%+1,428,043+58.2%Added
Price T Rowe Associates Inc4,620,823$58.5M0.01%−185,466−3.9%Reduced
EcoR1 Capital, LLC0$00.00%−254,473−100.0%Sold out
Woodline Partners LP0$00.00%−219,281−100.0%Sold out
Citadel Advisors LLC0$00.00%−211,783−100.0%Sold out
Regents of the University of California0$00.00%−204,123−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−120,750−100.0%Sold out
Two Sigma Investments, LP0$00.00%−91,335−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−69,850−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−33,003−100.0%Sold out
Laurion Capital Management LP0$00.00%−28,470−100.0%Sold out
Parkman Healthcare Partners LLC0$00.00%−20,663−100.0%Sold out
Squarepoint Ops LLC0$00.00%−20,516−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−15,963−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−15,034−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−12,350−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−12,200−100.0%Sold out
HSBC Holdings PLC0$00.00%−11,615−100.0%Sold out
ProShare Advisors LLC0$00.00%−10,489−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−1,109−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−269−100.0%Sold out
EMC Capital Management0$00.00%−288−100.0%Sold out
Signaturefd, LLC0$00.00%−48−100.0%Sold out
Covestor Ltd0$00.00%−13−100.0%Sold out
Susquehanna Fundamental Investments, LLC––––Not filed
Amalgamated Financial Corp.––––Not filed